modelN05CM05_1
Extends from Pharmacokinetic.Models.PK_1C.
Information
| name: | Scopolamine_1 | |
| ATC code: | N05CM05_1 | route: | transdermal |
| compartments: | 1 | |
| dosage: | 1.5 | mg |
| volume of distribution: | 4.6 | L |
| clearance: | 0.97 | L/h/kg |
| other parameters in model implementation | ||
Scopolamine is an anticholinergic agent used to prevent motion sickness and postoperative nausea/vomiting. It blocks the action of acetylcholine on smooth muscles, glands, and in the central nervous system.
Pharmacokinetics
Pharmacokinetics reported in healthy males and females after transdermal administration (1.5 mg/patch, delivering approximately 1 mg over 3 days).
References
Delgado-Charro, MB, & Guy, RH (2014). Effective use of transdermal drug delivery in children. Advanced drug delivery reviews 73 63–82. DOI:10.1016/j.addr.2013.11.014 PUBMED:https://pubmed.ncbi.nlm.nih.gov/24333231
Berner, B, & John, VA (1994). Pharmacokinetic characterisation of transdermal delivery systems. Clinical pharmacokinetics 26(2) 121–134. DOI:10.2165/00003088-199426020-00005 PUBMED:https://pubmed.ncbi.nlm.nih.gov/8162656
Guay, DR (2003). Clinical pharmacokinetics of drugs used to treat urge incontinence. Clinical pharmacokinetics 42(14) 1243–1285. DOI:10.2165/00003088-200342140-00004 PUBMED:https://pubmed.ncbi.nlm.nih.gov/14606931
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Modelica.Units.SI.Mass | weight (from PK_1C) | 75 | patient weight (kg) |
| Modelica.Units.SI.SpecificVolume | VdPerKg (from PK_1C) | 0.9 | Volume of distribution (L/kg) |
| Modelica.Units.SI.MassFraction | F (from PK_1C) | 0.8 | bioavailiability (0-1) |
| Pharmacolibrary.Types.Clearance | Cl (from PK_1C) | 20 | clearance |
| Modelica.Units.SI.Time | adminTime (from PK_1C) | 60 | first administration time (s) |
| Modelica.Units.SI.Time | adminDuration (from PK_1C) | 600 | administration duration (s) |
| Modelica.Units.SI.Time | adminPeriod (from PK_1C) | 8*60*60 | period of administration (default 8 hours)(s) |
| Pharmacolibrary.Types.Mass | adminMass (from PK_1C) | 1000 | administration mass (mg) |
| Integer | adminCount (from PK_1C) | 8 | number of dose administered (1) |
| Pharmacolibrary.Types.Volume | Vd (from PK_1C) | VdPerKg*weight | Volume of distribution (m3) |
| Pharmacolibrary.Types.MassConcentration | Cmin (from PK_1C) | 0.004 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Cmax (from PK_1C) | 0.008 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Ctox_peak (from PK_1C) | 0.012 | toxicity peak level |
| Pharmacolibrary.Types.MassConcentration | Ctox_trough (from PK_1C) | 0.006 | toxicity trough level |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Types.ConcentrationOutput | C_central (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | centralCPort (from PK_1C) |
Components
| Type | Name | Default | Description |
|---|---|---|---|
| Pharmacokinetic.NoPerfusedTissueCompartment | central (from PK_1C) | ||
| Pharmacokinetic.ClearanceDrivenElimination | elim (from PK_1C) | ||
| Sources.PeriodicDose | periodicDose (from PK_1C) | ||
| Modelica.Units.SI.Time | t1_2 (from PK_1C) | elimination half-life |
Revisions
- 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)